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Abstract
Background: Using a murine model of herpes simplex virus (HSV)-1 encephalitis, our laboratory has determined that 
induction of proinflammatory mediators in response to viral infection is largely mediated through a Toll-like receptor-2 
(TLR2)-dependent mechanism. Published studies have shown that, like other inflammatory mediators, reactive oxygen 
species (ROS) are generated during viral brain infection. It is increasingly clear that ROS are responsible for facilitating 
secondary tissue damage during central nervous system infection and may contribute to neurotoxicity associated with 
herpes encephalitis.
Methods: Purified microglial cell and mixed neural cell cultures were prepared from C57B/6 and TLR2-/- mice. 
Intracellular ROS production in cultured murine microglia was measured via 2', 7'-Dichlorofluorescin diacetate (DCFH-
DA) oxidation. An assay for 8-isoprostane, a marker of lipid peroxidation, was utilized to measure free radical-associated 
cellular damage. Mixed neural cultures obtained from β-actin promoter-luciferase transgenic mice were used to detect 
neurotoxicity induced by HSV-infected microglia.
Results: Stimulation with HSV-1 elevated intracellular ROS in wild-type microglial cell cultures, while TLR2-/- microglia 
displayed delayed and attenuated ROS production following viral infection. HSV-infected TLR2-/- microglia produced 
less neuronal oxidative damage to mixed neural cell cultures in comparison to HSV-infected wild-type microglia. 
Further, HSV-infected TLR2-/- microglia were found to be less cytotoxic to cultured neurons compared to HSV-infected 
wild-type microglia. These effects were associated with decreased activation of p38 MAPK and p42/p44 ERK in TLR2-/- 
mice.
Conclusions: These studies demonstrate the importance of microglial cell TLR2 in inducing oxidative stress and 
neuronal damage in response to viral infection.
Background
Exposure to an invading pathogen initially triggers robust
innate immune responses. These responses involve
recruitment and activation of phagocytic macrophages,
neutrophils and, during central nervous system infection,
the activation of resident microglia. One effective method
that immune cells utilize to eliminate invading pathogens
is through the rapid and robust production of reactive
oxygen species (ROS), termed the respiratory burst,
which facilitates damage to the invading pathogen. Some
of the reactive species generated include superoxide (O2-
), hydroxyl radical (OH), hydrogen peroxide (H2O2),
hypochlorite (OCl-), and peroxynitrite (OONO-). ROS
production, while beneficial in clearing invading patho-
gens, can also cause irreparable harm through bystander
damage to crucial host cells.
Herpes simplex virus (HSV)-1 infection of the brain
results in devastating necrotizing encephalitis. Using a
murine model of HSV-1 encephalitis our laboratory has
shown that intranasal delivery of HSV induces a robust
activation of brain microglial cells, production of proin-
flammatory mediators, and focal tissue damage which, if
left untreated, can result in prolonged brain inflamma-
tion, and compromised brain function or death [1-5]. It is
becoming increasingly clear that reactive species are
responsible for mediating many of the secondary mecha-
nisms of tissue damage during and subsequent to viral
brain infection, including herpes encephalitis [6].
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Microglial cell production of ROS is implicated in neu-
rototoxicity associated with HIV-associated dementia,
Alzheimer's disease, Parkinson's disease and Amyo-
trophic lateral sclerosis [7,8]. While in vitro studies in our
laboratory implicate microglial cells as the primary medi-
ator of proinflammatory cytokines and chemokines dur-
ing HSV-1 infection, little is known about ROS
production and its impact on the brain during viral
encephalitis. While reactive species themselves are short
lived and difficult to measure, detection of secondary
products such as lipid peroxidation (F2-isoprotanes and
F4-neuroprostanes), tyrosine nitrosylation and DNA-oxi-
dation (8-hydroxydeoxyguanosine) are useful indicators
of oxidative damage in vivo. Indeed, our laboratory has
detected increases in 8-isoprostane, 8-hydroxydeox-
yguanosine and 3-nitrotyrosine during active experimen-
tal herpes encephalitis [3]. Radical-induced tissue injury
has also been detected during latent herpes infection [6].
These studies indicate that the cytopathic effects
observed during HSV-1 encephalitis may not be simply
due to viral replication, but may result from additional
host-mediated secondary mechanisms involving the over
activation of microglial cells.
Microglial cells express a myriad of receptors from the
Toll-like receptor family (TLR) of pathogen recognition
receptors, including TLR2. TLR2-/- mice are less suscepti-
ble to HSV infection, highlighting the importance of this
receptor in the outcome of HSV encephalitis [9,10]. Using
a purified murine microglial cell culture system our labo-
ratory has shown that HSV-1 recognition through TLR2
plays a pivotal role in the initial inflammatory response
associated with viral infection including the production
of proinflammatory cytokines and chemokines, as well as
the induction of apoptosis [5,11-13]. In other models,
activation of TLR receptors has also been linked to ROS
production [14-16]. Data from these systems suggests a
potential role for TLR2 in the harmful effects of micro-
glial cell-induced oxidative stress during herpes encepha-
litis.
In this study, we tested the hypothesis that HSV-
induced neural cell oxidative tissue damage and cytotox-
icity are mediated by microglial cell ROS through a
TLR2-dependent mechanism. We detected elevated
intracellular ROS in HSV-infected microglia obtained
from wild-type mice. In contrast, the virus failed to
induce ROS in microglia obtained from TLR2-/- mice.
Additionally, compared to wild-type microglia, TLR2-/-
microglia displayed attenuated HSV-induced lipid perox-
idation and neurotoxicity. These studies demonstrate the
importance of microglial cell TLR2 in inducing oxidative
stress and neuronal damage in response to viral infection.
Methods
Neural cell cultures
Neural cell cultures were established from C57B/6, TLR2-
/- and transgenic β-actin promoter-luciferase Balb/c mice.
Following dispersion of fetal (d 15 of gestation) cerebral
cortices with trypsin, cells (5 × 105 or 2 × 105/500 ml)
were plated into collagen coated wells of 24-well plates
with DMEM containing 10% heat-inactivated fetal bovine
serum (FBS) and antibiotics. On day 5, the culture
medium was replaced with DMEM containing 10% heat-
inactivated FBS, uridine (33.6 mg/ml), and fluorodeoxyu-
ridine (13.6 mg/ml) to suppress glial cell growth. After 24
h, cells were replaced with DMEM containing 10% heat-
inactivated FBS. Culture medium was changed every 4
days thereafter. On day 7 the neural cell cultures con-
sisted of approximately 85-90% neurons (stained with a
rabbit anti-MAP-2 antibody (Chemicon; Temecula, CA)
and containing characteristic processes and birefringent
cell bodies), 10-15% astrocytes (stained with rabbit anti-
glial fibrillary acid protein antibody; Incstar, Stillwater,
MN), and < 2% microglia (stained with a rat anti-MAC-1
antibody; Roche Applied Science, Indianapolis, IN).
Microglial cell cultures
Murine cerebral cortical cells from 1-day-old C57B/6 and
TLR2-/-, mice were dissociated after a 30- min trypsiniza-
tion (0.25%) and were plated in 75-cm2 Falcon culture
flasks in DMEM containing 10% heat-inactivated FBS
and antibiotics. The medium was replenished 1 and 4
days after plating. On day 12 of culture harvested cells
were plated in a 60-mm petri dish and incubated for 15
min at 37°C. After extensive washing with culture
medium, adherent cells (microglia) were collected with a
rubber policeman and centrifuged at 1000 rpm for 10
min. Purified microglial cell cultures were comprised of a
cell population in which > 98% stained positively with
MAC-1 antibodies and < 2% stained positively with anti-
bodies specific to glial fibrillary acid protein, an astrocyte
marker.
Virus
HSV-1 strain 17 syn + was propagated and titrated using
plaque assay on rabbit skin fibroblasts (CCL68; American
Type Culture Collection, Manassas, VA).
Intracellular reactive oxygen species assay
The production of intracellular ROS was measured by
2',7'-Dichlorofluorescin diacetate (DCFH-DA; Sigma; St.
Louis, MO) oxidation. Murine microglial cultures seeded
(4 × 104/well) in 96-well plates or chamber slides were
infected with HSV-1 (MOI = 2). At designated time
points, cells were washed and incubated with HBSS con-
taining DCFH-DA (20 μM) for 30 min. After incubation,Schachtele et al. Journal of Neuroinflammation 2010, 7:35
http://www.jneuroinflammation.com/content/7/1/35
Page 3 of 8
cells were excited at 485 nm and DCFH-DA fluorescence
read at 530 nm emission on a fluorescence plate reader or
viewed and photographed under a fluorescence micro-
scope. Each sample was run in triplicate and sample
means were normalized to their respective controls (% of
control).
8-isoprostane assay
Purified murine microglia from wild-type and TLR2-/-
mice were infected with HSV-1 (2 MOI). Cells were har-
vested at 90 min p.i. and 5 × 104 or 1 × 105 microglia were
transferred onto mixed neural cultures (5 × 105/well)
from C57B/6 or TLR2-/- mice creating microglia to neu-
ron ratios of 1:10 and 1:5, respectively. To free the trans-
ferred microglia of residual HSV-1, the microglia were
treated prior to harvest with 0.05% trypsin for 10 min-
utes, followed by 3 washes with 10% FBS containing
DMEM. Transfer of 5 × 104 or 1 × 105 uninfected micro-
glia served as a control. Oxidative damage to lipids was
quantified by using an 8-isoprostane EIA kit according to
the manufacturer's instructions (Cayman; Ann Arbor,
MI).
Neurotoxicity assay
Purified murine microglia from wild-type and TLR2-/-
mice were infected with HSV-1 (2 MOI). Cells were har-
vested at 90 min p.i. and transferred, at the designated
microglia to neuron ratios (1:5, 1:20 and 1:40), onto cul-
tured neurons obtained from β-actin promoter-luciferase
transgenic mice. D-Luciferin potassium salt (Gold Bio-
technology; St. Louis, MO) was added to each well and
luciferase activity measured on a plate reader 48 h after
microglial cell transfer.
Western Blot
Microglia (2 × 106/well) were infected with HSV-1 (MOI
= 2). Thirty minutes following HSV-1 treatment cell
lysates were collected, electrophorezed in 12% acrylam-
ide/bis-acrylamide electrotransfered onto nitrocellulose
membrane and probed with rabbit anti-phospho-p38
MAP Kinase (Thr180/Tyr182) and rabbit anti-phospho-
p44/42 MAP Kinase (Thr202/Tyr204) antibodies (Cell
Signaling; Danvers, MA). Rabbit anti-p38 MAP Kinase
and rabbit anti-p42/p44 MAP kinase antibodies were
used to detect total p38 and p42/p44 levels (Cell Signal-
ing; Danvers, MA). Alkaline phosphatase-conjugated sec-
ondary antibodies with chemiluminescence detection
was used with a Kodak Image Station to capture protein
band images.
Statistical analysis
For comparison of means of multiple groups, analysis of
variance (ANOVA) was performed followed by either
Fisher's protected least significant difference (PLSD)-test
or Scheffe-test. For comparison of means of pairs of data
a two-tailed Student's T-test for paired samples was
applied.
Results
TLR2-/- microglial cells have blunted ROS production in 
response to HSV-1 infection
To determine the role of microglia and TLR2 on HSV-1
induced oxidative damage, we first examined ROS pro-
duction in wild-type microglia following HSV-1 infection
in vitro. Purified microglial cell cultures from wild-type
mice were inoculated with HSV-1 (MOI = 2), and at des-
ignated times following infection, cells were loaded with
the ROS fluorescence indicator DCFH-DA. A kinetic
analysis of microglial ROS production following HSV-1
challenge revealed increased intracellular ROS produc-
tion as early as 3 h.p.i. ROS continued to increase at 8 h
and 24 h, reaching peak ROS accumulation by 48 h.p.i.
(Figure 1). In contrast, levels of ROS obtained from
TLR2-/- microglia did not differ from uninfected controls
at 3 h, 8 h and 24 h.p.i. However, at 48 h and 72 h,
increased intracellular ROS accumulation was detected
Figure 1 HSV-1-infected TLR2-/- microglial cells have attenuated 
intracellular ROS production compared to wild-type microglial 
cells. Microglial cell cultures from wild type and TLR2-/- mice were in-
fected with HSV-1 (MOI = 2) and measured, at various time points, for 
ROS production. DCFH-DA (20 μM) was added 30 min before each 
time point and measured with a fluorescence plate reader. Data are 
normalized to ROS production in the uninfected control microglia and 
presented as the % of control ± SD and are representative of three sep-
arate experiments. * = p < 0.05.Schachtele et al. Journal of Neuroinflammation 2010, 7:35
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in HSV-infected TLR2-/- microglia. Comparison of HSV-
infected wild-type and TLR2-/- microglial ROS, normal-
ized and expressed as % of their respective uninfected
controls, revealed the blunted production of ROS by
TLR2-/-  microglia. ROS production in HSV-infected
TLR2-/- microglia was significantly less than wild-type
HSV-infected microglial at 3 h, (p = 0.043), 8 h (p =
0.026), 24 h (p = 0.022), and 48 h.p.i. (p = 0.042). These
data clearly demonstrate the importance of TLR2 in
HSV-induced microglial ROS production.
Mixed neural cultures from wild-type, but not TLR2-/- mice, 
produce oxidative damage in response to HSV-1 infection
Using a mixed neural cell culture model, we investigated
the extent to which HSV-1 infection induces neuronal
oxidative damage in vitro. HSV-1 (MOI = 1) was added to
C57B/6 or TLR2-/- mixed neural cell cultures (comprised
of ~90% neurons, ~10% astrocytes and < 2% microglia)
and the infected cultures were assessed for 8-isoprostane
levels, a marker of lipid peroxidation. Based on the peak
HSV-1-induced ROS production in microglial cells dem-
onstrated above, we chose to assess oxidative damage at
48 h.p.i. HSV-1 infection was found to increase 8-isopros-
tane levels in wild-type mixed neural cultures (p = 0.002).
In contrast, 8-isoprostane levels in TLR2-/- neural cul-
tures did not differ from untreated controls (p = 0.40),
demonstrating the importance of TLR2 in HSV-1
induced oxidative damage (Figure 2). Because microglia
are the TLR2 possessing cells in the brain [17], the lack of
8-isoprostane in TLR2-/- cultures also suggests that oxida-
tive damage due to direct HSV-1 infection of neurons and
astrocytes is negligible, although these experiments can-
not fully discount ROS production and its associated oxi-
dative damage by astrocytes and neurons.
TLR2 mediates microglial cell HSV-1 induced oxidative 
damage to mixed neural cultures
To investigate the importance of microglia in mediating
HSV-induced oxidative damage, we combined our mixed
neural cultures with HSV-infected or control microglial
cells in reconstituted cultures. In all of these experiments,
mixed neural cultures were derived from TLR2-/- mice
because TLR2-/- mixed neural cultures have a lower back-
ground level of 8-isoprostane than wild-type cultures and
are more suitable to assess the relative contribution of
microglia in virus-induced oxidative damage. In brief,
purified microglia cultures were infected with HSV-1 for
2 h prior to harvest and their subsequent addition to
mixed neural cultures. 8-isoprostane levels were mea-
sured at 36 h.p.i. If microglia contribute to 8-isoprostane
production in mixed neural cultures then the addition of
previously HSV-infected microglia to naïve mixed neural
cultures would increase 8-isoprostane levels. Indeed,
while uninfected wild-type and TLR2-/- microglia failed
to increase 8-isoprostane levels above those observed in
mixed neural cultures alone, the addition of HSV-
infected wild-type microglia to mixed neural cultures
increased 8-isoprosane levels in a dose-dependant man-
ner (Figure 3). In comparison to HSV-infected wild-type
microglia, addition HSV-infected TLR2-/-  microglia
resulted in the blunted production of 8-isoprostane in
reconstituted cultures at 5 × 104 microglia and 1 × 105.
Addition of HSV-infected TLR2-/-  microglia to mixed
neural cultures did induce a marked increase in 8-iso-
prostane over the addition of uninfected control micro-
glia at a density of 1 × 105 but not 5 × 104.
HSV-1 infected microglia from TLR2-/- mice produce less 
neurotoxicity when added to mixed neural cultures
Using neural cultures derived from β-actin promoter-
luciferase transgenic Balb/c mice, we were able to assess
neural cytotoxicity resulting from the addition of exoge-
nously added HSV-infected C57B/6 microglia. In this
assay, HSV-infected or control purified microglial cells
were added at specific ratios to mixed neural cultures
(microglia to neuron; 1:40, 1:20, 1:5) and luciferin emis-
sion measurements from each experimental group was
normalized to luciferin readings from untouched mixed
Figure 2 Elevated 8-isoprostane levels in mixed neural cell cul-
tures following HSV-1 infection. Mixed neural cell cultures obtained 
from wild-type or TLR2-/- mice were infected with HSV-1 (MOI = 1) for 
48 h prior to collecting supernatants for 8-isoprostane assay as an indi-
cator of lipid peroxidation. Data are presented as mean pg/mL of 8-iso-
prostane ± SD and are a representative of three separate experiments. 
** p < 0.01.Schachtele et al. Journal of Neuroinflammation 2010, 7:35
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neural cultures (expressed as % of control). Because β-
actin promoter-luciferase transgenic mice ubiquitously
express the luciferase enzyme, in these studies, a decrease
in luciferin intensity indicated a decrease in neural cell
number. Addition of HSV-infected wild-type C57B/6
microglia resulted in a significant decrease in neural cul-
ture luciferin emission at ratios of 1:20 (p < 0.001) and 1:5
(p < 0.001) indicating increased neurocytotoxicity (Figure
4). The cytotoxicity appears to be dependent on microglia
as evidenced by a more pronounced dose-dependent
decrease in luciferin emission with the addition of more
microglia. In contrast, addition of HSV-infected TLR2-/-
microglia failed to significantly decrease luciferin emis-
sion at 1:40 (p = 0.759), 1:20 (p = 0.067), and 1:5 (p =
0.052) microglia:neuron ratios and, hence, induced less
cytotoxicity. Interestingly, the addition of C57B/6 back-
ground microglia to the non-syngeneic Balb/c back-
ground mixed neuronal cultures was not problematic in
these experiments as evidenced by negligible neurotoxic-
ity upon addition of uninfected C57B/6 microglia to
Balb/c luciferase transgenic mixed neural cultures.
TLR2-/- microglial cells have reduced phosphorylated p38 
and p42/p44 in response to HSV-1
Our laboratory has found that HSV-1 signals through
TLR2 to activate NF-κB with a subsequent increase in
inflammatory mediator production [11,13,17]. Microglial
cell TLR2 can signal through alternative transduction
cascades including p38 MAPK and p44/p42 ERK1/2,
which have been implicated in free radial production
[14,15,18,19]. To further investigate the role of TLR2 sig-
naling in HSV-induced ROS production we investigated
the ability of HSV-1 to activate TLR2 downstream signal
transduction cascades. Addition of HSV-1 (MOI = 2) to
wild-type microglia resulted in increased phosphoryla-
tion of p38 MAPK and p42/p44 ERK1/2 as detected by
western blot. In contrast, a blunted p38 and p42/p44
phosphorylation response was observed using HSV-
infected TLR2-/- microglia (Figure 5).
Discussion
Herpes virus brain infection results in devastating
encephalitis from which, while drug therapies that inhibit
viral replication have succeeded in reducing mortality,
fewer than 20% of patients surviving herpes encephalitis
recover without significant long-term neuropathological
manifestations [1,20]. The mechanisms responsible for
these long-term neurological sequelae appear to involve
both viral-mediated damage and immune-mediated pro-
cesses. Using a murine model, our laboratory has detailed
the inflammatory and pathological time course of HSV-1
Figure 4 Decreased neurotoxicity from HSV-infected TLR2-/- mi-
croglia compared to wild-type cells. Purified murine microglia from 
wild-type and TLR2-/- mice were infected with HSV-1 (2 MOI). Cells were 
harvested at 90 min p.i. and transferred, at the designated microglia: 
neuron ratios, onto β-actin luciferase mixed neural cultures. Luciferin 
emission was measured 48 h after microglial cell transfer. Data were 
normalized to untouched β-actin luciferase mixed neural cultures and 
presented as the % of control. Data are presented as mean pg/mL of 8-
isoprostane ± SD and are a representative of three separate experi-
ments. *** p < 0.001.
Figure 3 HSV-infected microglial cells from TLR2-/- mice produce 
less neural oxidative damage than wild-type microglia when 
added to mixed brain cultures. Control or HSV-infected (MOI = 2) pu-
rified murine microglia from wild-type and TLR2-/- were transferred at 
concentrations of 5 × 104 or 1 × 105 to wells containing a mixed neural 
culture. Cultures were harvested 48 h after microglial cell transfer and 
assessed for 8-isoprostane production. Data are presented as mean 
pg/mL of 8-isoprostane ± SD and are a representative of three separate 
experiments.Schachtele et al. Journal of Neuroinflammation 2010, 7:35
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brain infection including identification of a robust and
prolonged microglial cell response [1,21]. In this study,
we show that HSV-induced ROS production in microglia,
the resident brain macrophage, is responsible for lipid
peroxidation and neurotoxicity in vitro. Furthermore, we
show that initial microglial ROS production during HSV
infection is mediated through TLR2.
Viral brain infection initiates a robust inflammatory
response pivoting on the production of cytokines and
chemokines by microglial cells [5]. The primary service of
microglial cell activation is to combat and control invad-
ing pathogens via release of chemokines and cytokines,
and subsequent recruitment of peripheral immune cells.
Another key strategy is the production of ROS to damage
and control the pathogen. However, excessive and pro-
longed ROS production and inflammatory responses may
be detrimental to sensitive host cells (i.e., uninfected
bystander neural cells). In the present study, we found
that HSV-infected wild-type microglia robustly produced
ROS with peak production of ROS at 48 h.p.i. (Figure 1).
The kinetics of microglial ROS production reported in
this study coincides with our previous publications
reporting that peak cytokine and chemokine release from
HSV-1 infected microglia occurs after 24 h.p.i. [5,11].
ROS production can dramatically impact the proinflam-
matory response of the inflammatory cell. Published
studies show that intracellular creation of free radicals by
NAPDPH oxidase drives proinflammatory cytokine pro-
duction in macrophages and microglia in response to
mycobacterium tuberculosis infection [15,22]. Further-
more, microglial ROS production through NADPH oxi-
dase has been shown to precede cytokine and chemokine
production [23-25].
The role of free radical-induced tissue injury has been
investigated during herpes encephalitis by detection of
F2-isoprotanes and F4-neuroprostanes, indicators of oxi-
dative lipid damage [6]. We corroborate this finding in
vitro using our mixed neural culture system where we
detected increased lipid peroxidation in response to
HSV-1 infection (Figure 2). Previous studies have also
found that oxidative tissue damage is related to microglial
ROS production in models using lipopolysaccharide
(LPS) and HIV-tat protein stimulation [26-28]. In this
study, we found a dose-dependent induction of 8-isopros-
tane in mixed neural cultures following the addition of
HSV-infected microglia from wild-type mice (Figure 3).
Using a similar study design, we found that microglia also
contribute to neurotoxicity during HSV-1 infection (Fig-
ure 4). This finding, together with HSV-1-induced ROS
production in microglia and lipid peroxidation in mixed
neural cultures, demonstrates the importance of micro-
glial cell ROS production in damage to neurons and pro-
vides evidence for the harmful effects of excess ROS
accumulation.
These experiments implicate microglial cells as the pri-
mary mediator of HSV-1 induced oxidative damage.
While we cannot discount the possible contribution of
free radical production from neurons and astrocytes in
elevating 8-isoprostane levels, the finding that proinflam-
matory oxidative stress during HSV-infection induced
oxidative damage (Figure 3) and is neurotoxic (Figure 4)
is important and may be broadly applied to other models
of viral brain infection.
TLR2 is an important pathogen recognition receptor
during HSV infection. Other laboratories have shown
that TLR2-/- mice are less susceptible to HSV-1, showing
lower mortality rates following viral infection [9]. In this
study, we found that HSV-induction of ROS is mediated
largely through TLR2, as indicated by the lack of ROS
accumulation in HSV-infected TLR2-/-  microglia. Fur-
thermore, TLR2-/- microglia had an attenuated ability to
induce HSV-infected microglial cell-mediated oxidative
tissue damage and neurotoxicity. However, lack of TLR2
did not completely prevent the production of ROS, 8-iso-
prostane and cytotoxicity in response to viral challenge.
Recognition of HSV through alternative pattern recogni-
tion receptors, whose mRNAs are ubiquitously expressed
in microglia, could provide an alternative route of viral
recognition [17]. TLR3, recognizing dsRNA, and TLR9,
recognizing high CpG motif carrying bacterial and viral
DNAs, are likely candidates and have been shown to
respond to HSV [29,30]. Another mechanism of cytokine
release in macrophages is through the recognition of
HSV-1 glycoprotein upon viral entry [31]. This occurs in
a TLR2-independent and nucleic acid-independent man-
Figure 5 HSV-induced p38 MAPK and p42/p44 ERK1/2 activation 
in primary microglia is attenuated TLR2-/- mice. Microglial cell cul-
tures from wild-type and TLR2-/- mice were infected with HSV-1 (MOI = 
2) for 30 min. Cell lysates were collected and probed for total and phos-
phorylated p38 MAPK and p42/p44 ERK1/2.
C57B/6 TLR2 -/-
C HSV C HSV
Phospho-p38
MAPK
Total p38 
MAPK
Phospho-p44/p42
ERK
Total p44/p42 
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ner. Based on data reported in this study, TLR2 remains a
pivotal primary trigger for the downstream effects of
HSV infection.
The canonical TLR signaling cascade after pathogen
recognition leads to the activation of NF-κB and the sub-
sequent production of proinflammatory mediators
[11,12,17]. In this study we show for the first time that
HSV-infection of microglia stimulates the MAPK signal
transduction cascade via elevating levels of phosphory-
lated p38 MAPK and p42/44 ERK1/2 (Figure 5). p38
MAPK and p44/p42 ERK1/2 phosphorylation are com-
monly associated with TLR signaling and have be impli-
cated in TLR induced ROS production [14,15,18,19]. In a
similar study, Yang et al. found that monocyte production
of ROS following exposure to tuberculin purified protein
preceded proinflammatory mediator production and
required TLR2 and p38 MAPK phosphorylation [18].
In the present study, we focused on the oxidative stress
response of microglial cells during HSV-1 infection and
the potential consequences of microglial ROS on neu-
rons. In addition, we demonstrate signaling through
TLR2 as a pivotal player in HSV-1 induced microglial cell
ROS production. Thus, inhibition of TLR2 signalling as
well as modulation of microglial cell ROS production, via
an increase in antioxidative stress proteins (e.g., glutathi-
one peroxidase-1, heme oxygenase-1), may be potential
targets in regulating unwanted bystander damage to
healthy neurons during viral brain infection.
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